These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38582102)

  • 1. A Low Transition Temperature Mixture-based viscosupplementation complemented with celecoxib for osteoarthritis treatment.
    Roda A; Paiva A; Rita C Duarte A
    Int J Pharm; 2024 May; 656():124088. PubMed ID: 38582102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet Rich Plasma and Hyaluronic Acid Blend for the Treatment of Osteoarthritis: Rheological and Biological Evaluation.
    Russo F; D'Este M; Vadalà G; Cattani C; Papalia R; Alini M; Denaro V
    PLoS One; 2016; 11(6):e0157048. PubMed ID: 27310019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the Addition of a Polyol to Hyaluronic Acid a Significant Advance in the Treatment of Osteoarthritis?
    Conrozier T
    Curr Rheumatol Rev; 2018; 14(3):226-230. PubMed ID: 28699498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comparison Between Rheological Properties of Intra-articular Hyaluronic Acid Preparations and Reported Human Synovial Fluid.
    Nicholls M; Manjoo A; Shaw P; Niazi F; Rosen J
    Adv Ther; 2018 Apr; 35(4):523-530. PubMed ID: 29542009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is Local Viscosupplementation Injection Clinically Superior to Other Therapies in the Treatment of Osteoarthritis of the Knee: A Systematic Review of Overlapping Meta-analyses.
    Campbell KA; Erickson BJ; Saltzman BM; Mascarenhas R; Bach BR; Cole BJ; Verma NN
    Arthroscopy; 2015 Oct; 31(10):2036-45.e14. PubMed ID: 25998016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active viscosupplements for osteoarthritis treatment.
    Pontes-Quero GM; García-Fernández L; Aguilar MR; San Román J; Pérez Cano J; Vázquez-Lasa B
    Semin Arthritis Rheum; 2019 Oct; 49(2):171-183. PubMed ID: 30878154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can Hyaluronic Acid Combined with Chondroitin Sulfate in Viscosupplementation of Knee Osteoarthritis Improve Pain Symptoms and Mobility?
    Dima A; Dragosloveanu M; Romila AR; Cristea A; Marinică G; Dănilă AT; Mandici A; Cojocariu D; Vlad RA; Ciurba A; Bîrsan M
    Biomolecules; 2024 Jul; 14(7):. PubMed ID: 39062546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editorial Commentary: Knee Hyaluronic Acid Viscosupplementation Reduces Osteoarthritis Pain.
    Lubowitz JH
    Arthroscopy; 2015 Oct; 31(10):2046. PubMed ID: 26433240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mannitol Preserves the Viscoelastic Properties of Hyaluronic Acid in an In Vitro Model of Oxidative Stress.
    Conrozier T; Mathieu P; Rinaudo M
    Rheumatol Ther; 2014 Dec; 1(1):45-54. PubMed ID: 27747759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A composite device for viscosupplementation treatment resistant to degradation by reactive oxygen species and hyaluronidase.
    Toropitsyn E; Pravda M; Rebenda D; Ščigalková I; Vrbka M; Velebný V
    J Biomed Mater Res B Appl Biomater; 2022 Dec; 110(12):2595-2611. PubMed ID: 35727166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duration of symptom relief after intra-articular injection of hyaluronic acid combined with sorbitol (anti-ox-vs) in symptomatic hip osteoarthritis.
    Migliore A; Massafra U; Bizzi E; Tormenta S; Cassol M; Granata M
    Int J Immunopathol Pharmacol; 2014; 27(2):245-52. PubMed ID: 25004836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viscosupplementation with hyaluronic acid in the treatment for cartilage lesions: a review of current evidence and future directions.
    Clegg TE; Caborn D; Mauffrey C
    Eur J Orthop Surg Traumatol; 2013 Feb; 23(2):119-24. PubMed ID: 23412441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-formulations of adalimumab with hyaluronic acid/polyvinylpyrrolidone to combine intraarticular drug delivery and viscosupplementation.
    Siefen T; Bjerregaard S; Plaksin D; Lokhnauth J; Liang A; Larsen CC; Lamprecht A
    Eur J Pharm Biopharm; 2022 Aug; 177():39-49. PubMed ID: 35691537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viscosupplementation of synovial fluid with xanthan gum for treatment of osteoarthritis and its clearance kinetics in the rabbit knee joint.
    Shao HR; Jin Y; Han GY; Jiang P; Zhu XQ; Liu F; Song ZG; Li M; Ling PX
    Biorheology; 2014; 51(4-5):305-14. PubMed ID: 25381135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-articular multifunctional celecoxib loaded hyaluronan nanocapsules for the suppression of inflammation in an osteoarthritic rat model.
    El-Gogary RI; Khattab MA; Abd-Allah H
    Int J Pharm; 2020 Jun; 583():119378. PubMed ID: 32360505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A placebo-controlled study comparing the efficacy of intra-articular injections of hyaluronic acid and a novel hyaluronic acid-platelet-rich plasma conjugate in a canine model of osteoarthritis.
    Lee MI; Kim JH; Kwak HH; Woo HM; Han JH; Yayon A; Jung YC; Cho JM; Kang BJ
    J Orthop Surg Res; 2019 Sep; 14(1):314. PubMed ID: 31533754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viscosupplementation for osteoarthritis.
    Wright KE; Maurer SG; Di Cesare PE
    Am J Orthop (Belle Mead NJ); 2000 Feb; 29(2):80-8; discussion 88-9. PubMed ID: 10695858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rethinking Viscosupplementation: Ultrasound- Versus Landmark-Guided Injection for Knee Osteoarthritis.
    Lundstrom ZT; Sytsma TT; Greenlund LS
    J Ultrasound Med; 2020 Jan; 39(1):113-117. PubMed ID: 31237389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viscosupplementation with intra-articular hyaluronic acid for treatment of osteoarthritis in the elderly.
    Abate M; Pulcini D; Di Iorio A; Schiavone C
    Curr Pharm Des; 2010; 16(6):631-40. PubMed ID: 20388073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viscosupplementation with high molecular weight native hyaluronan. Focus on a 1500-2000 KDa fraction (Hyalubrix®).
    Guidolin D; Franceschi F
    Eur Rev Med Pharmacol Sci; 2014; 18(21):3326-38. PubMed ID: 25487947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.